Prakt. lékáren. 2009; 5(1): 22-25

Conservative treatment of glaucoma

MUDr. Petr Mlčák
Oční klinika FN a LF UP Olomouc

Glaucoma is a chronic, progressive, irreversible optic neuropathy. Glaucoma management involves conservative, laser, and surgical



treatment: Conservative treatment consists in using eye drops containing antiglaucoma agents on a regular daily basis. These include

prostaglandin analogues and prostamide, beta blockers, carbonic anhydrase inhibitors, alpha-2 agonists, parasympathomimetics, their

fixed combinations, and hyperosmotic agents. The main goal of glaucoma treatment is to preserve sufficient visual function while minimizing

the impact on the quality of life of patients.

Keywords: glaucoma treatment, prostaglandin analogues, beta blockers, carbonic anhydrase inhibitors, alpha-2 agonists, parasympathomimetics.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mlčák P. Conservative treatment of glaucoma. Praktické lékárenství. 2009;5(1):22-25.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. European glaucoma society. Terminology and Guidelines for Glaucoma. Dogma, Savona - Italy, 2003; chapter 3.
    2. Růžičková E, Glaukom. Maxdorf: Praha, 2006; 36-67. Go to original source...
    3. Šebesta P. Konzervativní terapie glakomu, Kolektiv autorů Oční kliniky 1. LF UK a ÚVN v Praze, Glaukom - vybrané kapitoly, Nucleus HK, Hradec Králové, 2008; 133-156.
    4. Alagoz G, Gürel K, Bayer A, et al. A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients. Ophthalmologica. 2008; 222(2): 88-95. Epub 2008 Feb 22. Go to original source... Go to PubMed...
    5. Denis P, Lafuma A, Khoshnood B, et al. A meta-analysis of topical prostaglandin analogues intraocular pressure lowering in glaucoma therapy. Curr Med Res Opin. 2007 Mar; 23(3): 601-608. Go to original source... Go to PubMed...
    6. Holmstrom S, Buchholz P, Walt J, et al. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Curr Med Res Opin. 2005 Nov; 21(11): 1875-1783. Go to original source... Go to PubMed...
    7. Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006 Feb; 113(2): 239-246. Go to original source... Go to PubMed...
    8. Yildirim N, Sahin A, Gultekin S. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma. J Glaucoma 2008 Jan-Feb; 17(1): 36-39. Go to original source... Go to PubMed...
    9. Brasnu E, Brignole-Baudouin F, Riancho L, et al. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res. 2008 Apr; 33(4): 301-312. Go to original source... Go to PubMed...
    10. Sutton A, Gilvarry A, Ropo A. A comparative, placebocontrolled study od prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males. J Ocul Pharmacol Ther. 2007 Aug; 23(4): 359-365. Go to original source... Go to PubMed...
    11. Sutton A, Gouws P, Ropo A. Tafluprost, a new potent prostanoid receptor agonist: a dose-response study on pharmacodynamics and tolerability in healthy volunteers. Int J Clin Pharmacol Ther. 2008 Aug; 46(8): 400-406. Go to original source... Go to PubMed...
    12. Výborný P, Sejčková L. Antiglaukomatika - obsah konzervačních látek a spolupráce pacienta v léčebném režimu, Cesk Slov Oftalmol. 2006 Jul; 62(4): 270-272, 274. Go to PubMed...
    13. Škop B. Mikro-verze AISLP - ČR, Praha, 2008.
    14. Gandolfi SA, Sangermani C, Cimino L, et al. Is there a non IOP-related effect of brimonidine on visual field progression in human glaucoma? Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); April 25-29, 2004; Fort Lauderdale, FL.
    15. Cox JA, Mollan SP, Bankart J, et al. Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review. Br J Ophthalmol. 2008 Jun; 92(6): 729-734. Epub 2008 May 6. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.